Sep 9, 2025 08:19AM Guggenheim Downgrades Tourmaline Bio (TRML) to Neutral

Sep 9, 2025 07:09AM Wedbush Downgrades Tourmaline Bio (TRML) to Neutral Post Acquisition

Sep 8, 2025 02:56PM Tourmaline Bio (TRML) 2600 contracts of September 30 calls trade, share price up 6.4%

Aug 13, 2025 06:50PM Tourmaline Bio (TRML) Misses Q2 EPS by 90c

May 27, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Tourmaline Bio (TRML)

May 21, 2025 08:19AM Tourmaline Bio (TRML) PT Raised to $54 at Leerink Partners

May 21, 2025 08:06AM Truist Defends Tourmaline Bio (TRML) Post Data: 'We remain Buyers'

May 21, 2025 07:37AM BMO Capital Defends Tourmaline Bio (TRML): 'Why We Think PhII Data Is a Win; Stock Reaction Overblown'

May 20, 2025 07:33AM Tourmaline Bio (TRML) Announces Positive Topline Results from the Ongoing Phase 2 TRANQUILITY Trial Evaluating Pacibekitug in Patients with Elevated High-Sensitivity C-reactive Protein and CKD

May 19, 2025 04:06PM Tourmaline Bio (TRML) to Present Topline Results from the Ongoing Phase 2 TRANQUILITY Trial of Pacibekitug on May 20, 2025

May 2, 2025 04:24PM Tourmaline Bio (TRML) Misses Q1 EPS by 89c

Apr 23, 2025 09:36AM Cantor Fitzgerald Reiterates Overweight Rating on Tourmaline Bio (TRML)

Apr 23, 2025 04:14AM Chardan Capital Markets Starts Tourmaline Bio (TRML) at Buy

Apr 10, 2025 06:05AM Tourmaline Bio (TRML) PT Lowered to $63 at Truist Securities

Mar 14, 2025 06:46AM Tourmaline Bio (TRML) PT Raised to $50 at H.C. Wainwright

Mar 13, 2025 04:34PM Tourmaline Bio (TRML) Misses Q4 EPS by 86c

Feb 27, 2025 08:13AM Truist on Tourmaline Bio (TRML): 'CV Represents Significant Potential Upside Not Reflected at CMP'

Jan 10, 2025 07:31AM Tourmaline Bio (TRML) Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker

Jan 3, 2025 08:23AM Piper Sandler Explores Direct and Indirect Catalysts for Selected Biotechnology Companies

Dec 10, 2024 08:34AM Tourmaline Bio (TRML) Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day

Dec 5, 2024 04:12PM BMO Capital Starts Tourmaline Bio (TRML) at Outperform

Nov 12, 2024 06:57AM Tourmaline Bio (TRML) PT Raised to $49 at H.C. Wainwright

Nov 7, 2024 05:28PM Tourmaline Bio (TRML) Misses Q3 EPS by 78c

Nov 4, 2024 06:13AM Guggenheim Reiterates Buy Rating on Tourmaline Bio (TRML)

Oct 11, 2024 07:32AM Tourmaline Bio (TRML) to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress

Oct 11, 2024 06:26AM Guggenheim Reiterates Buy Rating on Tourmaline Bio (TRML)

Oct 8, 2024 07:32AM Tourmaline Bio (TRML) Announces Formation of Cardiovascular Scientific Advisory Board

Sep 11, 2024 07:03AM Truist Securities Reiterates Buy Rating on Tourmaline Bio (TRML)

Sep 7, 2024 08:00PM Here's the list of biotech stocks that have key data catalysts in 2025

Sep 4, 2024 07:42AM Piper Sandler Reiterates Overweight Rating on Tourmaline Bio (TRML)

Aug 8, 2024 08:28AM Tourmaline Bio (TRML) Misses Q2 EPS by 68c

Jun 27, 2024 08:05AM Tourmaline Bio (TRML) Announces the Promotion of Ryan Robinson to Chief Financial Officer